Financial Gravity Asset Management’s CareDx CDNA Stock Holding History

Financial Gravity Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8	Closed	–	–	1411
2019 Q3	$0	Buy	+8	New	+$222	﹤0.01%	1218

Other funds holding CDNA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Financial Gravity Asset Management's CDNA Position: Q4 2019 in Review

Financial Gravity Asset Management sold out of CareDx (CDNA) in Q4 2019, closing a stake of 8 shares.

Financial Gravity Asset Management first reported a position in CDNA in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

Financial Gravity Asset Management reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
Financial Gravity Asset Management sold 8 CareDx shares in Q4 2019.
Financial Gravity Asset Management first reported a position in CareDx in Q3 2019 and held it in 1 quarter.
Financial Gravity Asset Management's CareDx position peaked at $0 in Q3 2019.
159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.